Search Results 1-10 of 17267 for TNF

1. Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye

   They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the balancing acts of medicine, the anti-inflammatory action of ...

2. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

   Approved in 1998 for use in treating Crohn's disease and subsequently in 2005 for treating ulcerative colitis, anti-tumor necrosis factor (TNF) agents have ...

3. Clinical Outcomes Of Medications Post Anti-TNF: Researching Effectiveness In Pediatric IBD

   The purpose of this study is to compare the effectiveness of specific therapies to treat children with CD and UC/IBD-U refractory to anti-TNF therapy.

4. Rheumatoid arthritis finding may lead to new inflammation blockers - Mayo Clinic News Network

   Rheumatoid arthritis is an autoimmune disorder characterized by chronic inflammation, including high levels of a cytokine called tumor necrosis factor, or TNF.

5. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

   About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...

6. Adrian T. Ting, Ph.D. - Mayo Clinic Faculty Profiles

   Ting's lab studies primarily post-translational mechanisms that dictate cell survival versus death in response to tumor necrosis factor (TNF). Even though TNF ...

7. Research finds JAK inhibitors don't increase risks for patients with IBD - Mayo Clinic

   ... tumor necrosis factor-alpha (TNF-a) antagonists. Unlike some previous research comparing JAK and TNF-a antagonists, the Mayo Clinic study focused ...

8. Study To Determine Risk Factors For Post-operative Infection In Inflammatory Bowel Disease - Mayo Clinic

   ... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...

9. Study To Determine Risk Factors For Post-operative Infection In Inflammatory Bowel Disease - Mayo Clinic

   ... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...

10. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) ...